Sale of Accuscience to Diploma plc.

Accuscience’s shareholder Pharmed had received an inbound approach regarding the sale of Accuscience. Pharmed Limited appointed Capnua to run a competitive sales process to target large strategic multinationals specialising in sales, marketing, and distribution in the healthcare sector.

Accuscience distributes life sciences and medtech equipment to the Irish & Northern Irish healthcare sectors, including clinical diagnostics, blood tracking, resuscitation and mobile/modular healthcare facilities.

Diploma plc is an international group of specialist businesses providing essential products and expertise to customers across a wide range of sectors – from aerospace to healthcare. Headquartered in the United Kingdom, Diploma is a FTSE 100 company with a market capitalisation in excess of £7 billion and has operations across North America, the UK, Europe and Australia.

Declan Devine

Pharmed Group

Capnua’s insight into corporate M&A was critical in structuring a competitive sale process for Accuscience. Their clear, strategic advice supported both shareholders and management every step of the way.